ArticleClinical and translational science2022

Effect of renal impairment on the pharmacokinetics and safety of dorzagliatin, a novel dual-acting glucokinase activator.

Jia Miao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.